Table of Contents
China Botulinum Neurotoxins Market Research Report 2016
1 Botulinum Neurotoxins Market Overview
     1.1 Product Overview and Scope of Botulinum Neurotoxins
     1.2 Botulinum Neurotoxins Segment by Type
            1.2.1 China Production Market Share of Botulinum Neurotoxins Type in 2015
            1.2.2 Botulinum Neurotoxins A (BoNT/A)
            1.2.3 Botulinum Neurotoxins B (BoNT/B)
            1.2.4 Botulinum Neurotoxins E (BoNT/E)
            1.2.5 Botulinum Neurotoxins F (BoNT/F)
            1.2.6 Botulinum Neurotoxins C (BoNT/C)
            1.2.7 Botulinum Neurotoxins D (BoNT/D)
            1.2.8 Botulinum Neurotoxins G (BoNT/G)
     1.3 Applications of Botulinum Neurotoxins
            1.3.1 Botulinum Neurotoxins Consumption Market Share by Application in 2015
            1.3.2 Medical Uses
            1.3.3 Cosmetics
            1.3.4 Application 3
     1.4 China Market Size (Value) of Botulinum Neurotoxins (2011-2021)
     1.5 China Botulinum NeurotoxinsStatus and Outlook
     1.6 Government Policies
2 China Botulinum Neurotoxins Market Competition by Manufacturers
     2.1 China Botulinum Neurotoxins Capacity, Production and Share by Manufacturers (2015 and 2016)
     2.2 China Botulinum Neurotoxins Revenue and Share by Manufacturers (2015 and 2016)
     2.3 China Botulinum Neurotoxins Average Price by Manufacturers (2015 and 2016)
     2.4 Manufacturers Botulinum Neurotoxins Manufacturing Base Distribution, Sales Area, Product Type
     2.5 Botulinum Neurotoxins Market Competitive Situation and Trends
            2.5.1 Botulinum Neurotoxins Market Concentration Rate
            2.5.2 Botulinum Neurotoxins Market Share of Top 3 and Top 5 Manufacturers
3 China Botulinum Neurotoxins Manufacturers Profiles/Analysis
     3.1 Johnson & Johnson
            3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
            3.1.2 Botulinum Neurotoxins Product Type, Application and Specification
                    3.1.2.1 Type I
                    3.1.2.2 Type II
            3.1.3 Johnson & Johnson Botulinum Neurotoxins Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
            3.1.4 Main Business/Business Overview
     3.2 GSK
            3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
            3.2.2 121 Product Type, Application and Specification
                    3.2.2.1 Type I
                    3.2.2.2 Type II
            3.2.3 GSK 121 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
            3.2.4 Main Business/Business Overview
     3.3 Allergan
            3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
            3.3.2 127 Product Type, Application and Specification
                    3.3.2.1 Type I
                    3.3.2.2 Type II
            3.3.3 Allergan 127 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
            3.3.4 Main Business/Business Overview
     3.4 Chong Kun Dang
            3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
            3.4.2 Sept Product Type, Application and Specification
                    3.4.2.1 Type I
                    3.4.2.2 Type II
            3.4.3 Chong Kun Dang Sept Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
            3.4.4 Main Business/Business Overview
     3.5 Eisai
            3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
            3.5.2  Product Type, Application and Specification
                    3.5.2.1 Type I
                    3.5.2.2 Type II
            3.5.3 Eisai  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
            3.5.4 Main Business/Business Overview
     3.6 Nestle
            3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
            3.6.2 Million USD Product Type, Application and Specification
                    3.6.2.1 Type I
                    3.6.2.2 Type II
            3.6.3 Nestle Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
            3.6.4 Main Business/Business Overview
     3.7 Galderma
            3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
            3.7.2 Pharmaceuticals Product Type, Application and Specification
                    3.7.2.1 Type I
                    3.7.2.2 Type II
            3.7.3 Galderma Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
            3.7.4 Main Business/Business Overview
     3.8 Ipsen
            3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
            3.8.2  Product Type, Application and Specification
                    3.8.2.1 Type I
                    3.8.2.2 Type II
            3.8.3 Ipsen  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
            3.8.4 Main Business/Business Overview
     3.9 Hugel
            3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
            3.9.2  Product Type, Application and Specification
                    3.9.2.1 Type I
                    3.9.2.2 Type II
            3.9.3 Hugel  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
            3.9.4 Main Business/Business Overview
     3.10 Mentor
            3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
            3.10.2  Product Type, Application and Specification
                    3.10.2.1 Type I
                    3.10.2.2 Type II
            3.10.3 Mentor  Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
            3.10.4 Main Business/Business Overview
     3.11 CROMA
     3.12 Alphaeon
     3.13 OBI Pharma
     3.14 Revance Therapeutics
     3.15 Daewoong Pharmaceutical
     3.16 Medy-Tox
     3.17 EpiVax
     3.18 Anterios
     3.19 Escape Therapeutics
     3.20 Lipella
     3.21 Malvern Cosmeceutics
     3.22 PharmaVital
     3.23 Merz Pharma
     3.24 Transdermal
     3.25 Valeant Pharmaceuticals
     3.26 CNBG
4 China Botulinum Neurotoxins Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)
     4.1 China Botulinum Neurotoxins Capacity, Production and Growth (2011-2016)
     4.2 China Botulinum Neurotoxins Revenue and Growth (2011-2016)
     4.3 China Botulinum Neurotoxins Production, Consumption, Export and Import (2011-2016)
5 China Botulinum Neurotoxins Production, Revenue (Value), Price Trend by Type
     5.1 China Botulinum Neurotoxins Production and Market Share by Type (2011-2016)
     5.2 China Botulinum Neurotoxins Revenue and Market Share by Type (2011-2016)
     5.3 China Botulinum Neurotoxins Price by Type (2011-2016)
     5.4 China Botulinum Neurotoxins Production Growth by Type (2011-2016)
6 China Botulinum Neurotoxins Market Analysis by Application
     6.1 China Botulinum Neurotoxins Consumption and Market Share by Application (2011-2016)
     6.2 China Botulinum Neurotoxins Consumption Growth Rate by Application (2011-2016)
     6.3 Market Drivers and Opportunities
            6.3.1 Potential Application
            6.3.2 Emerging Markets/Countries
7 Botulinum Neurotoxins Manufacturing Cost Analysis
     7.1 Botulinum Neurotoxins Key Raw Materials Analysis
            7.1.1 Key Raw Materials
            7.1.2 Price Trend of Key Raw Materials
            7.1.3 Key Suppliers of Raw Materials
            7.1.4 Market Concentration Rate of Raw Materials
     7.2 Proportion of Manufacturing Cost Structure
            7.2.1 Raw Materials
            7.2.2 Labor Cost
            7.2.3 Manufacturing Expenses
     7.3 Manufacturing Process Analysis of Botulinum Neurotoxins
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
     8.1 Botulinum Neurotoxins Industrial Chain Analysis
     8.2 Upstream Raw Materials Sourcing
     8.3 Raw Materials Sources of Botulinum Neurotoxins Major Manufacturers in 2015
     8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
     9.1 Marketing Channel
            9.1.1 Direct Marketing
            9.1.2 Indirect Marketing
            9.1.3 Marketing Channel Development Trend
     9.2 Market Positioning
            9.2.1 Pricing Strategy
            9.2.2 Brand Strategy
            9.2.3 Target Client
     9.3 Distributors/Traders List
10 Market Effect Factors Analysis
     10.1 Technology Progress/Risk
            10.1.1 Substitutes Threat
            10.1.2 Technology Progress in Related Industry
     10.2 Consumer Needs/Customer Preference Change
     10.3 Economic/Political Environmental Change
11 China Botulinum Neurotoxins Market Forecast (2016-2021)
     11.1 China Botulinum Neurotoxins Capacity, Production, Revenue Forecast (2016-2021)
     11.2 China Botulinum Neurotoxins Production, Import, Export and Consumption Forecast (2016-2021)
     11.3 China Botulinum Neurotoxins Production Forecast by Type (2016-2021)
     11.4 China Botulinum Neurotoxins Consumption Forecast by Application (2016-2021)
     11.5 Botulinum Neurotoxins Price Forecast (2016-2021)
12 Research Findings and Conclusion
13 Appendix
    Author List
    Disclosure Section
    Research Methodology
    Data Source
    China Disclaimer